A University of Virginia School of Medicine project has received $12.5 million from the National Institutes of Health. The project aims to understand how a form of cell communication might shed light on how to tackle a wide range of diseases.
Funding from the National Heart, Lung and Blood Institute will support five years of research into how cells communicate through pannexin channels in their membranes, according to a news release. By understanding how pannexin channels function, scientists hope to be able to better predict how new drugs will interact with those channels and whether the drugs are likely to be effective for their prescribed purpose.
The new funding adds to a previous grant of $12.5 million over the past five years, which has led to highly circulated published work.
Scientists say the research could have implications for cancer, diabetes, cardiovascular disease, fatty liver disease and inflammation.